Sebastian River Holdings, Inc.’s Synerlife Health Corp. Enters Multi-Billion Dollar Nutraceutical Industry Toward Near-Term...
April 25 2013 - 9:00AM
Business Wire
Sebastian River Holdings, Inc. (OTC:SBRH), a diversified
holdings company, is pleased to announce that it’s wholly-owned
subsidiary, Synerlife Health Corporation, Inc., expects to launch
with ready-for-market product(s) in Q2 2013, toward near-term
revenues and exponential growth for Sebastian including overall
increase in shareholder value.
Synerlife has entered negotiations to partner with a
nutraceutical company specializing in biochemical and
pharmacological features of both natural supplements and
pharmaceutical drugs with formulas based on biblical principles.
The company is to design and manufacture products specifically for
Synerlife as proprietary formulas exclusive to the company and will
be marketed by a third party to be contracted by Sebastian as CEO
of Synerlife.
Currently, the primary candidate for CEO/CMO has shown strong
interest in proceeding immediately to create financial and brand
success for Synerlife products. As well, the company expects to
finalize negotiations with both the CEO/CMO candidate and the
product design expert within the next 2 weeks.
“We couldn’t be more excited about this development,” states
SBRH Director, Peter Matousek. “It comes with great thanks to our
funding partner in the Midwest who made the introduction for
Synerlife. He feels strongly about the prospects of Synerlife
toward inherent growth for Sebastian River Holdings, specifically
as it relates to building shareholder value in the company moving
forward.”
Synerlife Health Corporation, Inc., will specialize in Chinese
herbal wellness products, powerful antioxidant formulas, effective
testosterone boosters, healthy weight loss and fat burning
solutions as well as health and energy beverage drinks.
More to come on this exciting venture as negotiations are
finalized.
MARKET STATEMENT- NUTRACEUTICALS
According to Global Information, Inc., the global market for
Nutraceuticals is projected to reach US$250 billion by 2018.
Performance-wise, Nutraceuticals registered a steady growth pattern
in the post-recession years. An aging population has been a major
factor contributing to this growth of the nutraceuticals
market.
By the year 2020, the number of individuals who are aged 60
years and above is expected to surpass 1.0 billion, with 70% of
this populace dwelling in the developing nations. The
nutraceuticals industry is geared to meet the rising demand for
health foods and products as companies with sufficient capital for
scientific research enter the nutraceuticals space.
The trend towards personalized health nutrition is expected to
provide solutions to successfully prevent, manage, and treat
chronic medical illnesses. Also, the availability and accessibility
of healthy foods in the developing nations, evolving understanding
of the concepts that promote healthy living, and the launch of
targeted foods and products scientifically formulated to address
disease conditions are expected to support the growth of the
nutraceuticals market in the near future.
This release includes forward-looking statements, which are
based on certain assumptions and reflects management’s current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include: general global economic conditions; general
industry and market conditions, sector changes and growth rates;
uncertainty as to whether our strategies and business plans will
yield the expected benefits; increasing competition; availability
and cost of capital; the ability to identify and develop and
achieve commercial success; the level of expenditures necessary to
maintain and improve the quality of services; changes in the
economy; changes in laws and regulations, including codes and
standards, intellectual property rights, and tax matters; or other
matters not anticipated; our ability to secure and maintain
strategic relationships and distribution agreements. The Company
disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise.
Contact: Sebastian River Holdings, Inc. Peter Matousek,
424-258-0167
Global Pole Trusion (PK) (USOTC:GPGC)
Historical Stock Chart
From Apr 2024 to May 2024
Global Pole Trusion (PK) (USOTC:GPGC)
Historical Stock Chart
From May 2023 to May 2024
